Prescribing Information

Gavreto and Rozlytrek are subject to a conditional marketing authorisation.

Medicinal products that display the black triangle symbol ▼ are subject to additional monitoring. This will allow quick identification of new safety information. Healthcare professionals are asked to report any suspected adverse reactions. Adverse events should be reported. Reporting forms and information can be found at www.mhra.gov.uk/yellowcard. Adverse events should also be reported to Roche Products Ltd. Please contact Roche Drug Safety Centre by emailing welwyn.uk_dsc@roche.com or calling +44 (0)1707 36 7554. For medicines which are biological, healthcare professionals should report adverse reactions by brand name and batch number.
You will be re-directed to an external website. Roche accepts no responsibility for the content of other websites.